Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Return on Equity (2016 - 2025)

Dexcom (DXCM) has disclosed Return on Equity for 15 consecutive years, with 0.31% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 2.0% to 0.31% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.31% through Dec 2025, up 2.0% year-over-year, with the annual reading at 0.34% for FY2025, 7.0% up from the prior year.
  • Return on Equity for Q4 2025 was 0.31% at Dexcom, up from 0.27% in the prior quarter.
  • The five-year high for Return on Equity was 0.37% in Q1 2021, with the low at 0.1% in Q2 2022.
  • Average Return on Equity over 5 years is 0.23%, with a median of 0.25% recorded in 2025.
  • The sharpest move saw Return on Equity rose 20bps in 2021, then dropped -26bps in 2022.
  • Over 5 years, Return on Equity stood at 0.11% in 2021, then soared by 57bps to 0.17% in 2022, then soared by 45bps to 0.25% in 2023, then increased by 13bps to 0.28% in 2024, then grew by 8bps to 0.31% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 0.31%, 0.27%, and 0.24% for Q4 2025, Q3 2025, and Q2 2025 respectively.